These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1590210)

  • 1. DPS--the PMA perspective.
    Beary JF; Cleveland CB
    Am Pharm; 1992 May; NS32(5):6, 8. PubMed ID: 1590210
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment: Pharmacy and generic substitution of antiepileptic drugs: missing in action?
    Hatton RC
    Ann Pharmacother; 2007 Sep; 41(9):1550-1; author reply 1551-2. PubMed ID: 17652128
    [No Abstract]   [Full Text] [Related]  

  • 3. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
    Heller WM
    Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
    [No Abstract]   [Full Text] [Related]  

  • 4. Lawsuits anticipated on generic biologicals front.
    Fox JL
    Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
    [No Abstract]   [Full Text] [Related]  

  • 5. Current issues in the pioneer versus generic drug wars.
    Safir PO
    Food Drug Law J; 1995; 50(2):335-9. PubMed ID: 10343002
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioequivalence/bioavailability retention samples.
    Ransom C
    Qual Assur; 1993; 2(1-2):42-3. PubMed ID: 8156218
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In U.S., biosimilars still await FDA decision.
    Finkelstein JB
    J Natl Cancer Inst; 2006 Apr; 98(7):435. PubMed ID: 16595775
    [No Abstract]   [Full Text] [Related]  

  • 9. Generic drug substitution.
    Rogowski A; Lemay V
    Med Health R I; 2001 Jul; 84(7):241-4. PubMed ID: 11482281
    [No Abstract]   [Full Text] [Related]  

  • 10. Generic vs. brand name drugs--quality, not cost, is key issue.
    Stetler CJ
    Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133
    [No Abstract]   [Full Text] [Related]  

  • 11. What's in a name? Generic vs brand name drugs.
    Levin AA
    Health PAC Bull; 1986 Jun; 16(5):37, 39. PubMed ID: 10276741
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic drugs.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 May; (IB61):1-18. PubMed ID: 12807116
    [No Abstract]   [Full Text] [Related]  

  • 13. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 14. The generic drug approval process.
    Rheinstein PH
    Am Fam Physician; 1993 Dec; 48(8):1357-60. PubMed ID: 8249762
    [No Abstract]   [Full Text] [Related]  

  • 15. Generic drugs: an overview.
    Helgeland D
    S D Med; 2006 Apr; 59(4):161-3. PubMed ID: 16681165
    [No Abstract]   [Full Text] [Related]  

  • 16. Generic Drugs.
    Med Lett Drugs Ther; 2002 Oct; 44(1141):89-90. PubMed ID: 12405134
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genericum? Which one should I choose?].
    Kovács G
    Neuropsychopharmacol Hung; 2013 Mar; 15(1):2. PubMed ID: 23542753
    [No Abstract]   [Full Text] [Related]  

  • 18. Generic drug purchasing.
    Mehl B
    Hosp Pharm; 1988 Feb; 23(2):162-4 contd. PubMed ID: 10286432
    [No Abstract]   [Full Text] [Related]  

  • 19. Substituting generic drugs: state roles.
    Cauchi R
    NCSL Legisbrief; 2009; 17(25):1-2. PubMed ID: 19526654
    [No Abstract]   [Full Text] [Related]  

  • 20. PMA suit addresses the real issue.
    J Indiana State Med Assoc; 1979 Mar; 72(3):163. PubMed ID: 422861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.